{
  "abstract": "The US has long supported global immunisation through bilateral funding via the US Agency for International Development (USAID) and the Centres for Disease Control and Prevention (CDC) and multilateral funding to Gavi, the Vaccine Alliance (Gavi). However, these programmes face a crisis after the abrupt funding suspension in 2025.",
  "authors": [
    {
      "affiliations": [
        "Institute of Science Tokyo, Tokyo, Japan",
        "NGO Reaching Zero-Dose Children, Tokyo, Japan"
      ],
      "name": "Aomi Katagiri"
    },
    {
      "affiliations": [
        "NGO Reaching Zero-Dose Children, Tokyo, Japan",
        "Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA"
      ],
      "name": "Yuka Iijima"
    },
    {
      "affiliations": [
        "Graduate School of Infomatics, Kyoto University, Kyoto, Japan",
        "Institute for Pharmaceutical and Social Health Sciences, Ise, Japan"
      ],
      "name": "Yoshiki Tanaka"
    },
    {
      "affiliations": [
        "NGO Reaching Zero-Dose Children, Tokyo, Japan",
        "Yokohama University of Pharmacy, Yokohama, Kanagawa, Japan"
      ],
      "name": "Hikari Ohyama"
    },
    {
      "affiliations": [
        "Institute for Pharmaceutical and Social Health Sciences, Ise, Japan",
        "Graduate School of Interdisciplinary Science and Engineering in Health Systems, Okayama University, Okayama, Japan"
      ],
      "name": "Takuya Nakazawa"
    },
    {
      "affiliations": [
        "Institute for Pharmaceutical and Social Health Sciences, Ise, Japan",
        "Eberhard Karls University Tubingen, Interfaculty Institute of Biochemistry, Tübingen, BW, Germany"
      ],
      "name": "Hayase Hakariya"
    }
  ],
  "title": "Japan’s emerging role in bridging immunisation gap and supporting global health",
  "uid": "8e85961a-577c-558b-8372-464f6470b686"
}
